(SCAP) Series Portfolios Trust - Ratings and Ratios
Small, Capitalization, Value, ETF
Description: SCAP Series Portfolios Trust
The Series Portfolios Trust (NYSE ARCA:SCAP) is an ETF that focuses on investing in small-capitalization companies, allocating at least 80% of its net assets to securities within this market segment. The fund defines small-cap companies as those with market capitalizations within or below the range of the Russell 2000 Index, providing a benchmark for its investment universe.
As a Small Value ETF, SCAP is designed to capture the performance of undervalued small-cap companies in the US market. Its investment strategy is centered around identifying companies with lower market capitalizations that have the potential for growth or are currently undervalued by the market.
Analyzing the technical data, we can observe that SCAPs last price is $31.99, slightly above its 20-day Simple Moving Average (SMA) of $31.88, indicating a potential bullish trend. The 50-day SMA is $31.30, further supporting this trend. However, the 200-day SMA at $33.45 suggests that the ETF is currently trading below its longer-term average, potentially signaling a buying opportunity. The Average True Range (ATR) of 0.47, or 1.46%, indicates moderate volatility.
From a fundamental perspective, the Assets Under Management (AUM) for SCAP stand at $13.86 million USD, a relatively modest size that could impact liquidity but also indicates a focused investment strategy. Given its small size and specific investment mandate, SCAP may appeal to investors seeking targeted exposure to small-cap value companies.
Forecasting SCAPs performance, we can anticipate that if the current bullish trend continues, with the ETF remaining above its 20-day and 50-day SMAs, it may attract more investors, potentially driving the price upwards. However, if the ETF fails to break through the resistance level around its 200-day SMA, it may face a correction. Considering the current ATR, a price movement of around 1.46% can be expected in the short term. Therefore, a potential target price could be around $32.50, representing a 1.5% increase from the current price, assuming the bullish trend persists and the ETF continues to attract investors focused on small-cap value.
SCAP ETF Overview
Market Cap in USD | 15m |
Category | Small Value |
TER | 0.80% |
IPO / Inception | 2023-12-11 |
SCAP ETF Ratings
Growth Rating | 52.3% |
Fundamental | - |
Dividend Rating | 73.7% |
Return 12m vs S&P 500 | -6.67% |
Analyst Rating | - |
SCAP Dividends
Dividend Yield 12m | 6.77% |
Yield on Cost 5y | 8.73% |
Annual Growth 5y | 420.60% |
Payout Consistency | 66.7% |
Payout Ratio | % |
SCAP Growth Ratios
Growth Correlation 3m | 74.9% |
Growth Correlation 12m | 0.4% |
Growth Correlation 5y | 67.4% |
CAGR 5y | 17.73% |
CAGR/Max DD 5y | 0.73 |
CAGR/Mean DD 5y | 5.03 |
Sharpe Ratio 12m | 0.94 |
Alpha | 0.00 |
Beta | 0.829 |
Volatility | 15.87% |
Current Volume | 2.2k |
Average Volume 20d | 1.8k |
Stop Loss | 34.3 (-3.2%) |
Signal | 3.45 |
What is the price of SCAP shares?
Over the past week, the price has changed by +0.69%, over one month by +5.90%, over three months by +9.93% and over the past year by +12.47%.
Is Series Portfolios Trust a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SCAP is around 43.78 USD . This means that SCAP is currently undervalued and has a potential upside of +23.53% (Margin of Safety).
Is SCAP a buy, sell or hold?
What are the forecasts/targets for the SCAP price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 49.1 | 38.4% |
Last update: 2025-09-05 04:58
SCAP Fundamental Data Overview
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 USD
Beta = 0.0
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 14.8m USD (14.8m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 14.8m)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 14.8m / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default)
NOPAT = 0.0 (EBIT 0.0, no tax applied on loss)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(14.8m)/V(0.0) * Re(9.06%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 9.06% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for SCAP ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle